State of Medtech

What makes a medical technology worth backing with millions?

Omar Khateeb sits down with Terri Burke, Senior Partner at Intuitive Ventures, to explore how the fund evaluates MedTech and healthcare innovation.

Terri draws on 30+ years as an operator, founder, and investor. Intuitive Ventures invests from seed through growth, with initial checks of $5 million to $10 million. She explains why strong technology still needs clinical evidence, customer demand, workflow fit, sound economics, and venture-scale return potential.

They also discuss AI, category creation, market validation, fundraising, founder-investor relationships, and why brand building should begin before commercialization.

DISCLAIMER
This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Conduct your own due diligence.

EPISODE BREAKDOWN
00:00 Great MedTech Starts With the Right Problem
00:45 Intro
01:05 Meet Terri Burke
02:09 Operator to Founder and Investor
04:52 Lessons From Building and Exiting
06:02 Why Service Providers Matter
07:22 Why Operators Make Better Investors
08:51 Lessons From Frontline Experience
10:08 Market Engineering and Growth
12:15 Understanding Customers
13:26 You Cannot Build a Market From Outside
15:01 Intuitive Ventures' Philosophy
15:30 Investing Beyond Robotics
16:55 Intuitive's Quintuple Aim
18:07 Why Intuitive Ventures Is Different
20:08 Why Early Funding Is Harder
20:45 Supporting Portfolio Companies
22:16 What Does a $5M to $10M Investment Look Like?
22:50 Evaluating Startups and Exits
24:33 Funds and the OrganOx Exit
25:25 How the Strategy Is Evolving
27:24 What Makes HealthTech Investable?
28:10 Clinical Value vs AI Hype
29:42 Medical Device Cybersecurity
30:26 Where AI Creates Value
31:19 AI in Cardiology
32:39 Sustainable AI Business Models
33:39 Can Platform MedTech Attract VC?
34:16 Pitch Solutions, Not Technology
35:31 Why Category Creation Matters
36:42 Proving Market Demand
38:01 Why Seed Companies Struggle
38:45 What Separates Fundable Startups?
39:37 Great Product vs Great Business
41:24 Reverse Engineering the Exit
42:09 Validate the Market First
43:02 What Early Traction Matters?
43:27 Pitching With Limited Clinical Data
44:41 Market-Product Fit First
45:57 Why Investors Want Category Leaders
46:56 HATICOR and Cardiology
48:07 Intuitive Ventures Portfolio
49:03 Neuromodulation Opportunities
51:04 Research Investors Before Pitching
52:07 Building VC Relationships
53:51 LinkedIn and Fundraising
54:07 Build the Brand Early
55:05 Why Late Marketing Is a Mistake
56:11 Shaping the Market Narrative
56:58 Branding Beyond Logos
57:12 Terri Burke on Mentorship
57:43 Relationships Create Career Value
59:14 Building Meaningful Relationships
01:00:40 Why Personal Connections Matter
01:01:56 How to Pitch Intuitive Ventures
01:02:12 Why Warm Introductions Matter
01:03:09 Building VC Connections
01:04:12 What Intuitive Ventures Looks For
01:05:15 Final Advice
01:05:44 Closing Remarks
01:06:00 End

MedTech CEO? Attract investors and grow your sales pipeline at GrowMyMedtech.com

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf

#medtechrevolution #venturecapital #medtechinnovation #healthcarestartup #medtechindustry

The biggest opportunity in cardiovascular AI may come from revealing risk that conventional imaging does not fully explain.

Omar Khateeb sits down with Steve Deitsch, CEO of Caristo Diagnostics, to discuss CaRi-Heart, an FDA-authorized AI technology that quantifies coronary inflammation from routine CCTA imaging.

Before Caristo, Steve served as CFO of OrganOx and helped lead its $1.5 billion acquisition by Terumo. He explains why strong technology is only the beginning. Enterprise value also requires clinical relevance, commercial execution, and disciplined capital allocation.

They explore how coronary inflammation could improve cardiovascular risk assessment, how Caristo plans to scale in the US, and why existing CCTA infrastructure creates a path for software innovation.

Steve also discusses a 2,000-patient NHS pilot in which nearly 60% of patients had a change in clinical management after CaRi-Heart analysis, plus opportunities in prevention, heart failure, AFib, stroke, and pharma.

DISCLAIMER
This podcast is for informational purposes only and is not financial, investment, legal, or medical advice. Views are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any security.

EPISODE BREAKDOWN
00:00 Why 61% of First Heart Attack Patients Are Low Risk
01:42 Meet Steve Deitsch
03:04 Lessons From a $1.5B MedTech Exit
03:29 What Creates Strategic Value?
05:21 Building a Valuable MedTech Business
06:11 Why Steve Almost Rejected OrganOx
06:42 What Made OrganOx Successful?
08:30 Why Category-Defining Innovation Matters
09:10 From OrganOx to Caristo
10:21 What Is Caristo?
10:31 Detecting Coronary Inflammation
11:59 Market Engineering and MedTech Growth
14:37 Turning FDA Authorization Into Growth
15:00 Why Measuring Inflammation Matters
15:30 Building Caristo's US Commercial Team
16:52 Could Consumers Pay for AI Heart Screening?
18:09 Could Omar Get a Caristo Scan?
19:03 Why Prevention Is More Personal
20:40 Why MedTech Could Benefit From AI
21:54 The Problem With Health Wearables
22:16 How Early Detection Changes Behavior
22:55 Why Calcium Scores Can Miss Risk
23:30 Non-Contrast Inflammation Screening
25:33 Could Heart Scans Go Mainstream?
27:04 How AI Imaging Changes Decisions
27:48 Why Heart Attacks Hit Low-Risk Patients
29:16 How Caristo's AI Imaging Works
29:28 Adding AI to Existing CT Scans
31:00 Personalized Heart Risk Scores
32:22 Can Caristo Become a Multibillion-Dollar Company?
32:59 The Coronary Inflammation Market
34:00 Predicting Stroke and Heart Failure
34:58 How MedTech CEOs Build Enterprise Value
35:47 Growth vs Long-Term Innovation
37:31 Why Pharma Needs MedTech Innovation
38:37 Caristo's Pharma Partnerships
40:10 Why Traditional Tests Miss Heart Disease
41:04 Why Partnerships Matter for Healthcare AI
41:39 How Caristo Develops Its AI
42:39 What Founders Get Wrong About Value
43:29 Building a MedTech Company Worth Billions
44:30 Build to Last, Not Chase an Exit
45:20 Learning and Leadership
47:28 End

MedTech CEO? Attract investors and sales growth at GrowMyMedtech.com

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf

#medtechinnovation #cardiovascularhealth #aiinhealthcare #heartdiseaseprevention #medtechrevolution

In this episode, Omar Khateeb sits down with Henry Peck, Chief Business Officer at LSI, for a September and October edition of This Month in MedTech covering major exits, surgical robotics, regulatory shifts, and strategic capital.

More than $4 billion in European MedTech exits set the stage. Henry shares LSI data showing that 77% of more recent LSI Europe companies are pursuing an FDA-first pathway, compared with roughly 14% prioritizing CE Mark or MDR first.

They explore why strategics are getting involved earlier as investors, commercialization partners, and distribution channels, not just future acquirers.

The episode also examines J&J’s roughly $400 million Laminar deal, Enovis’ €155 million acquisition of eCential Robotics, Stryker’s 3,000-system Mako footprint, and its $400 million investment in CMR Surgical.

Across robotics, neuromodulation, imaging, cardiovascular care, dialysis, and orthopedics, one theme stands out: strong technology still needs disciplined capital allocation and scalable commercialization.

DISCLAIMER

This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Conduct your own due diligence.

EPISODE BREAKDOWN

00:00 Orthopedic Robotics and Implant Revenue
01:17 September and October 2026
02:00 $4B in European MedTech Exits
03:17 LSI Europe 2026 Highlights
05:16 Five Innovators to Watch
07:32 Why European Startups Prioritize FDA
09:20 Emerging Companies to Watch
10:10 Precisis and Epilepsy Treatment
12:15 Positrigo and Compact Brain PET Imaging
13:22 Market Engineering and MedTech Growth
15:19 Smaller Imaging Systems
16:45 Positrigo and Alzheimer's Diagnosis
18:20 Brain PET and Alzheimer's
19:59 Xeltis, Strategics and Dialysis
21:35 Why Startups Partner Earlier
23:20 Xeltis and Regenerative Vascular Implants
25:20 Xeltis Clinical Data and DaVita
27:48 Why J&J Walked Away From $400M Deal
30:02 Why Laminar Is Returning as Jaguar LAA
30:55 What J&J's Divestiture Means for LAA Closure
33:00 Could Jaguar LAA Become a Major Success?
35:04 Rethinking Capital Allocation
36:50 Can Rejected Assets Still Succeed?
37:30 Enovis Acquires eCential Robotics for €155M
38:14 Moximed's Implantable Knee Shock Absorber
40:17 Robotics Deal Valuations
41:15 What Enovis Gains From eCential Robotics
42:37 Why Implant Revenue Drives Robotics
44:00 Can Independent Robotics Survive?
45:30 How Mako's Installed Base Creates an Advantage
46:44 Redefine Surgery and Physical AI
48:15 Why Stryker Invested $400M in CMR Surgical
49:23 Stryker: Invest, Distribute, Learn and Acquire
50:30 Stryker vs Intuitive and Medtronic
52:32 What Stryker and Olympus Reveal
53:25 Olympus Invests $31.5M in Max-Q Medical
54:10 Why Physical AI Is Attracting VC
55:00 Why Robotics Needs Strong Economics
55:50 Founder Lessons From These Deals
57:48 End

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf
Medtech CEO Camp: https://www.campcuriae.com/

#medtech #medtechinnovation #surgicalrobotics #medicaldeviceindustry #physicalai

MedTech may be entering an era where the most valuable companies are built as platforms.

Omar Khateeb sits down with Nick Damiano of Andromeda Surgical and Dave Messina of Pioneer Fund to explore TechMed, autonomous surgery, VC, and startups.

Nick explains how software, regulation, focused use cases, and rapid feedback can make MedTech more scalable. Andromeda starts narrow and builds toward broader autonomy.

Dave shares what Pioneer Fund looks for before revenue: speed, insight, customer pull, ambition, and learning.

They also discuss founder leadership, FDA plans, AI hype, moats, and fundamentals.

DISCLAIMER
This podcast is for informational purposes only and is not financial, investment, legal, or medical advice. Views are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Do your own due diligence.

EPISODE BREAKDOWN
00:00 Can Autonomous Robots Beat Surgeons?
01:12 Meet Nick Damiano and Dave Messina
02:12 Pioneer Fund and Andromeda
02:50 Early MedTech Needs Conviction
03:44 Is MedTech VC Falling Behind?
04:19 Silicon Valley's MedTech View
05:24 What Is TechMed?
07:23 Moving at Software Speed
08:55 Category-Defining Innovation
10:05 FDA and Autonomy
11:16 Incremental Innovation
12:15 Market Engineering
14:14 Faster Feedback Loops
15:20 Faster Development
16:29 Robotic Surgery Efficiency
17:11 Data vs Revenue
17:53 What Investors Want Pre-Revenue
20:11 Platform, Not Product
20:48 Building an Advantage
21:44 Andromeda's Strategy
22:30 Automation and Speed
23:20 Why Data Comes First
24:12 Uber Lessons for Robotics
24:44 Network Effects
25:27 What Makes Founders Investable?
27:00 Unconventional Founders
28:46 Replacing Founders?
30:31 Founder-Led Companies
31:02 Y Combinator Lessons
32:25 Founder-Led Healthcare
33:45 Business Model Innovation
35:03 Conviction vs Coachability
35:17 Great Founders Keep Learning
36:37 Can Silicon Valley Work in MedTech?
37:45 Why Founder Mode Matters
38:41 Andromeda's Founding Team
39:31 Building the Business
40:35 AI and Competitive Advantage
42:19 Why Pioneer Backed Andromeda
42:57 Can Autonomous Robots Improve Safety?
44:55 Starting With One Procedure
46:44 Small Problems, Big Breakthroughs
47:32 Beachhead Markets
48:29 Why Focus Matters
49:15 Waymo Lessons for Surgery
49:45 Why a16z Backs Autonomy
50:46 Why Competition Helps
51:13 Advice for New Startups
51:39 Why General Autonomy Is Hard
53:45 Is AI Hype Distorting MedTech?
55:03 Why Big Claims Need Evidence
55:42 Small Milestones, Big Breakthroughs
57:15 Why Magical Thinking Fails
58:15 Founders Need Open Minds
59:09 How Experience Creates Bias
01:00:31 Hiring for Learning
01:01:24 Young Talent vs Experience
01:02:43 Big MedTech vs Startups
01:04:06 Challenging Assumptions
01:04:43 Speed and Regulatory Rigor
01:05:25 Why Saying No Matters
01:06:23 Focus Accelerates Innovation
01:07:18 Avoiding Distractions
01:08:13 Rejecting Traditional Models
01:08:53 Why Copying Intuitive Loses
01:09:34 Intuitive Surgical Lessons
01:10:25 Software and Robotics
01:11:10 Follow Nick and Dave
01:12:00 End

MedTech CEO? Need help attracting investors? Visit GrowMyMedtech.com for a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf
CEO Camp: https://www.campcuriae.com/

#autonomousrobots #surgicalrobotics #medtechinnovation #physicalai #medtechindustry

a16z says physical technology is becoming important again. What could that mean for MedTech?

Omar Khateeb analyzes a16z’s State of Markets 2026 report and explores how AI, robotics, infrastructure, and changing venture economics could reshape the investment case for medical technology.

One theme stands out: capital is moving into industries that require hardware, manufacturing, infrastructure, and substantial upfront investment. Those are challenges MedTech already understands.

Omar explains why physical AI could bring healthcare into an investment cycle. Surgical robotics, intelligent devices, AI-enabled diagnostics, and specialized automation combine software intelligence with real-world systems.

But adding AI is not enough. MedTech founders need strong clinical evidence, economics, adoption, defensibility, scalability, and a credible path to category leadership.

The opportunity may not come from making medical devices look more like software. It may come from recognizing that physical technology itself is becoming strategically important again.

DISCLAIMER
This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence.

EPISODE BREAKDOWN

00:00 Why Physical AI Could Transform MedTech
01:07 a16z State of the Markets
02:05 Rethinking Capital-Intensive Tech
03:15 Why Physical Tech Is Back
04:15 Could MedTech Attract New Investors?
05:14 Why A16Z Says Atoms Are Back
06:20 Capital Intensity Is No Longer a Dealbreaker
07:25 Could VC Shift Toward Medical Devices?
08:33 Healthcare as a Physical AI Market
09:10 Why Surgical Robotics Fits Physical AI
10:00 Why Humanoid Robots Aren't Always the Answer
11:05 How MedTech Can Gain an Advantage
11:45 Why AI Investors Are Entering Robotics
12:42 Market Engineering and MedTech Growth
14:40 How Venture Economics Are Changing
15:35 Rethinking the MedTech Investment Pitch
16:30 What Investors Want From MedTech
17:30 Why Category Leadership Matters
18:30 Building a MedTech Investment Narrative
19:25 Why Adding AI Won't Raise Valuation
20:17 Why AI Needs Clinical Value
21:00 Why VC Returns Are More Concentrated
22:00 How MedTech Investors Can Compete
22:45 Why AI Adoption Is Still Early
23:40 What Hospitals Want From Healthcare AI
24:35 Clinical Validation as an Advantage
25:10 The SaaS Prove-It Era
26:10 Why Vertical AI Could Win
27:00 Great Businesses vs Great Technologies
27:40 The $90 Trillion Physical Infrastructure Shift
28:25 Healthcare as a Robotics Market
29:10 Attracting Capital and Talent
29:45 Innovation From Outside Healthcare
30:18 A16Z's Untapped Opportunities
31:05 What Physical AI Means for Founders
31:55 MedTech Investing in the Next Decade
32:20 QSBS Tax Benefits and Final Thoughts
33:33 End

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf
Medtech CEO Camp: https://www.campcuriae.com/

#medtech #physicalai #venturecapital #surgicalrobotics #medtechindustry

Space exploration may be approaching a bottleneck: the human body.

Omar Khateeb speaks with Matthew Kuhn, CEO of Skybound Medtech, to explore space medicine, autonomous care and robotics.

Microgravity accelerates muscle and bone loss, while deep-space communication delays can make real-time support from Earth impractical.

They discuss autonomous surgery, physical AI, reusable devices, remote diagnostics, and why space could become an innovation engine for healthcare on Earth.

DISCLAIMER
This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Conduct your own due diligence.

EPISODE BREAKDOWN
00:00 Why Space Medicine Could Change Healthcare
01:07 Meet Matthew Kuhn
02:24 From J&J to MedTech
03:30 Skunk Works and MedTech Innovation
05:03 Could Zero Gravity Transform Medicine?
06:11 Why Space Needs New MedTech
07:53 Manufacturing Medicine in Space
09:09 Surgery in Zero Gravity
10:16 NASA's Twin Study
11:19 Telomeres and Longevity
12:43 Space Research and Longevity
13:30 Market Engineering
15:28 Human Health in Space
15:52 Osteoporosis in Space`
16:11 Bone and Muscle Loss
17:23 Life After Long Missions
18:46 Why Space Is Dangerous
19:11 Is Space Medicine a New Category?
20:44 Space as an Innovation Engine
21:17 How Space Research Helps Earth
22:18 Why MedTech Needs Moonshots
23:23 Autonomous Surgery in Space
24:59 Why Disposables Won't Work on Mars
26:07 Space and Autonomous Surgery
26:30 A Heart Attack in Space
26:59 Mars Delays and Remote Surgery
27:40 NASA and Space Medicine
28:48 The Changing Space Economy
30:22 NASA's Moon Base and ISS
30:47 Private Space Stations
32:06 AI and Space Innovation
33:55 Skybound's Business Model
34:20 Space, Defense and Longevity
35:26 Making Deep Tech Investable
35:58 Space Medicine Investors
36:13 Why MedTech VC Is Hard
37:01 Space and Defense Funding
37:33 Why Investors Demand Revenue
39:18 Silicon Valley Investing
39:47 Why MedTech VC Moves Later
41:20 Could Space Attract New Investors?
42:04 The Rise of BCI Startups
42:28 Leading BCI Companies
43:51 Motif Neurotech
44:52 Colossal and De-Extinction
45:44 De-Extinction Technology
46:43 Lessons From Colossal
47:20 Moonshots and Opportunity
48:39 The Skybound Story
50:35 Rockets and Healthcare
51:07 Is Physiology the Bottleneck?
52:14 Curiosity and MedTech
53:48 Growth Hormones and Physiology
54:44 Preventing Bone and Muscle Loss
55:19 How Skybound Chooses Tech
56:08 Testing Devices for Space
56:34 NVIDIA AI and Discovery
58:26 New MedTech Discovery Models
58:39 Can Digital Twins Model Biology?
59:45 Is Skybound a Venture Studio?
01:00:10 How Skybound Spins Out Startups
01:01:27 Why Houston Could Lead
01:02:06 Space or Earth First?
01:02:25 Why Skybound Starts With Space
01:03:01 Final Thoughts
01:03:32 Follow Matthew and Skybound
01:04:00 End

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf
Medtech CEO Camp: https://www.campcuriae.com/

#spacemedicine #medtechinnovation #spaceexploration #medicalrobotics #healthcareinnovation #medtech

Surgical demand keeps rising, but the answer may not be more rooms, staff, or complex robotic systems.

Omar Khateeb sits down with Jeffery Alvarez, Chief Strategy Officer at Moon Surgical, to explore Scalable Surgery and how physical AI, workflow design, and ASC economics could reshape surgical robotics.

Jeffery explains why healthcare needs better execution, not simply more capacity. ASCs use specialized workflows, fast room turnover, predictable procedures, and higher throughput.

They discuss Moon Surgical’s Maestro platform, a physical AI system designed to perceive, reason, and act in the OR. Its Copilot capability tracks instruments and adjusts visualization automatically.

Jeffery also shares reported data from 300+ patients, including shorter procedure times, lower staffing needs, and roughly 30 to 35 percent greater predictability.

The conversation covers ASC economics, cost per procedure, network effects, AI ecosystems, startup focus, and scalable technology.

DISCLAIMER
This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any security. Conduct your own due diligence.

EPISODE BREAKDOWN
00:00 Why Surgical Robotics Needs a New Model
01:32 Meet Jeff Alvarez of Moon Surgical
02:36 Building Six Robotic Platforms
03:58 Introducing Scalable Surgery
04:44 What Is Scalable Surgery?
05:51 Why Healthcare Needs It Now
07:23 Why Hospital Margins Are Collapsing
09:10 Why ASCs Are More Profitable
10:02 How ASCs Perform More Surgeries
10:57 Why Patients Choose Outpatient Care
11:50 How Convenience Reshapes Care
12:45 Why Surgical Efficiency Matters
13:29 Inside Moon Surgical's Maestro Platform
14:05 How Maestro Uses Physical AI
15:32 Market Engineering and MedTech Growth
17:32 Why Moon Surgical Differs From Da Vinci
18:37 Why Traditional Robots Fit Another Era
20:30 Why More Complex Robotics Is Not Always Better
22:12 How Maestro Reduces OR Setup Time
23:28 Can Scalable Surgery Be Profitable?
24:06 Clinical Data Behind Maestro
25:28 What Makes Maestro Physical AI?
26:28 How AI Automates Camera and Setup
29:04 What Qualifies as Scalable Surgery?
29:58 Why Network Effects Matter
30:26 How AI Could Make Surgery More Efficient
32:30 Moon Surgical's Business Model
32:53 The Future of Maestro Software
34:21 Lessons From the Category Launch
34:44 What Toyota Can Teach Surgical Robotics
36:18 Applying First Principles
36:37 Why Moon Surgical Celebrates Saying No
37:33 How Maestro Reduces Cost Per Procedure
39:15 How Startup Constraints Become an Advantage
40:53 How Culture Shapes Moon Surgical
41:51 How Surgeons Are Responding
43:18 Why Surgeons Need Care Economics
44:45 Why High-Volume Surgery Needs a Different Model
46:18 What's Next for Moon Surgical?
46:47 Where to Follow Moon Surgical
48:14 End

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf
Medtech CEO Camp: https://www.campcuriae.com/

#surgicalrobotics #scalablesurgery #physicalai #medtechinnovation #moonsurgical

Remote surgery becomes far more interesting when you stop thinking about moving a robot and start thinking about moving expertise.

In this episode, Omar Khateeb sits down with Brian Miller, CEO of SOVATO, to explore how remote procedures could reshape specialized care.

Brian explains why robotics is only one part of the equation. It depends on secure infrastructure, reliable connectivity, clinical workflows, workforce planning, and AI-enabled autonomy.

They explore how hospital networks could centralize specialist coverage, allowing fewer experts to support more facilities. Brian also describes surgical cockpits where physicians connect into procedures remotely.

The conversation covers remote ultrasound, interventional radiology, urology, stroke care, AI, surgical autonomy, data, reimbursement, CMS, and choice.

The goal: bring expertise to the patient.

DISCLAIMER
This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified professionals.

EPISODE BREAKDOWN
00:00 How Remote Surgery Could Transform Access
01:08 Meet Brian Miller, CEO of Sovato
02:35 Why Millions Lack Specialized Care
03:52 How Sovato's Remote Platform Works
05:29 Three Technologies Driving Remote Surgery
06:20 Robotics, Infrastructure and AI
07:48 Why Remote Surgery Needs Better Infrastructure
08:49 Why Is Remote Surgery Taking Off Now?
09:13 Physician Shortages and Remote Care
10:47 When Surgical Expertise Crosses Borders
11:10 Market Engineering and MedTech Growth
13:22 Could Remote Surgery Give Patients More Choice?
14:41 Building Remote Care Programs
15:04 Why Remote Care Needs a Complete Solution
16:13 Is Sovato Software or Services?
17:06 Measuring Remote Surgery Success
17:28 Economics of Remote Surgery
19:38 Could Surgeons Work From Command Centers?
20:28 Inside the Future Surgical Cockpit
21:47 Which Procedures Will Adopt First?
22:09 Remote Ultrasound to Robotic Cancer Surgery
24:20 The First Breakthrough Remote Procedure
25:13 Why IR and Urology Could Lead
27:18 Opportunities in Medical Robotics
27:37 Robotics for Stroke Treatment
29:16 Who Buys Remote Surgery Technology?
29:38 Sovato's Business Model
31:14 Security, Integration and Reimbursement
32:42 How Will AI Fit Into Remote Surgery?
33:19 AI and the Future of Surgical Autonomy
34:29 Could Surgical Data Train Better AI?
35:59 Sharing Data Across MedTech
36:17 Who Owns Surgical Data?
37:13 Sovato and Telecom Providers
37:28 Reliable Networks for Remote Procedures
38:29 Why Remote Care Goes Beyond Surgery
39:01 Connecting Expertise Across Distance
40:37 Could Remote Care Change Insurance?
41:37 How Patients Could Drive Adoption
42:40 What's Next for Sovato?
46:00 Final Thoughts

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf
Medtech CEO Camp: https://www.campcuriae.com/

#remotesupport #surgicalrobotics #medtech #healthcareinnovation #medicalrobotics

In this episode, Jacob McLaughlin welcomes Omar Khateeb for a conversation about medical device sales, MedTech leadership, entrepreneurship, market strategy, and building long-term career leverage.

Omar shares how his career evolved from surgical robotics and medical device sales into marketing, Silicon Valley, entrepreneurship, and MarketCraft, where he focuses on MedTech market engineering for early-stage companies.

A central theme is personal ownership. Omar argues that professionals should not wait for a promotion before learning how leaders think. Studying management, business economics, commercialization, strategy, and decision-making early can change the opportunities available later.

Jacob and Omar also explore self-investment through books, mentorship, LSI conferences, professional relationships, and deliberate learning.

The discussion expands into category design, positioning, messaging, thought leadership, clinical adoption, fundraising, and focused go-to-market execution. Omar explains why investors increasingly look for traction and de-risking beyond regulatory progress alone.

They also unpack first-principles thinking, beachhead markets, technology adoption, and reference density, showing why concentrated success in one segment can create stronger credibility than broad but shallow activity.

DISCLAIMER
This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified professionals before making decisions.

Episode Breakdown
00:00 Think Like a Leader Before Becoming One
01:17 Omar Khateeb Returns
08:40 From Medical Device Sales to Entrepreneur
12:09 From Solopreneur to MarketCraft
13:38 What Is Market Engineering?
15:43 Market Engineering and MedTech Growth
17:40 Medical Device Sales as a Career Launchpad
20:59 Think Like an Executive Before Becoming One
22:17 Why More Responsibility Accelerates Your Career
24:00 Building Successful Habits Early
29:43 Your Career Development Is Your Responsibility
31:09 Why Investing in Yourself Pays Off
32:51 Core Principles of Market Engineering
37:14 First Principles Thinking
38:31 Why MedTech Needs a Beachhead Market
40:10 How Intuitive Surgical Built Reference Density
41:45 Why Focus Is a Competitive Advantage
43:50 Think Beyond the Traditional Career Ladder
47:51 Why MedTech Fundraising Is Harder Today
49:55 MedTech M&A and Competition
54:31 Why MedTech Difficulty Creates Defensibility
57:48 Why Narrative Is a Competitive Advantage
01:00:52 Startup vs Big MedTech
01:04:19 Building Valuable Professional Relationships
01:10:04 Staying Top of Mind
01:12:15 Build Relationships at Every Career Level
01:18:05 You May Be Millimeters From a Breakthrough
01:19:23 Keep Going Through Failure
01:22:33 Strategic Alliances Create Leverage
01:26:34 The Importance of Mentors
01:27:14 Where to Follow Omar
01:28:49 End

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
X: https://x.com/OmarMKhateeb

Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf
Medtech CEO Camp: https://www.campcuriae.com/

#surgicalrobotics #medtech #surgery #medicalrobotics #healthcareinnovation

In this episode, Omar Khateeb speaks with Sudhir Srivastava, MD, Founder, Chairman & CEO of SS Innovations International Inc., on how surgical robotics and telesurgery could reshape access to care.

Dr. Srivastava shares his journey from cardiac surgeon to MedTech founder and the development of the SSi Mantra surgical robotic platform, built to make robotic surgery more affordable and accessible.

That vision is already moving into real-world telesurgery. Dr. Srivastava says SS Innovations has completed nearly 200 remote surgical procedures, including robotic cardiac cases, with surgeries spanning thousands of kilometers and one telesurgery reaching roughly 20,000 kilometers.

The conversation explores how telepresence could support a hub-and-spoke model, allowing specialist surgeons to reach smaller hospitals remotely. Dr. Srivastava also discusses 24 telesurgeries in 12 hours, remote mentoring, and low-latency robotic cardiac procedures.

They also examine AI, machine learning, semi-automation, mobile operating rooms, remote diagnostics, surgeon training, robotic emergency systems, and technologies for underserved regions.

The bigger question is how robotic surgery, connectivity, AI, and training can make specialist surgical expertise available wherever patients need it.

DISCLAIMER

This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified professionals before making decisions.

EPISODE BREAKDOWN

00:00 Why Building a Surgical Robotics Company Is So Hard
01:04 Meet Dr. Sudhir Srivastava and SS Innovations
02:19 From Cardiac Surgeon to MedTech Founder
07:02 The Patient Story That Changed Everything
08:36 Building an Affordable Surgical Robot
13:03 Why SS Innovations Took a Different Path From Da Vinci
20:43 How Fred Moll Joined the Journey
24:01 Building a New Surgical Robot in Five Months
27:41 Building a World-Class Robotics Team in India
30:26 The Future of Robotics, AI and Minimally Invasive Surgery
33:02 Could Surgical Expertise Become Independent of Geography?
34:03 Nearly 200 Telesurgeries
34:38 Performing Cardiac Surgery Remotely
35:59 24 Telesurgeries in 12 Hours
37:58 Bringing Robotic Surgery to Rural Communities
39:28 Building a Mobile Robotic Operating Room
40:37 Could Medical Drones Save Lives?
42:01 Democratizing Access to Robotic Surgery
43:19 SS Innovations’ Global Expansion
46:03 What Technologies Will Transform Surgery Next?
47:50 Why Telesurgery Is More Than Hype
49:03 Telesurgery for Training and Remote Care
50:57 Are Humanoid Surgical Robots Overhyped?
51:36 How AI and Robotics Could Transform Medicine
52:56 What’s Next for SS Innovations?
57:22 End

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

Market Engineering Training:
https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf

Medtech CEO Camp in Boston:
https://www.campcuriae.com/

#surgicalrobotics #telesurgery #medtech #roboticsurgery #medicalrobotics #healthcareinnovation